Earn MIPS Improvement Activity Credits

By Contributing COVID Images and Data to ACR Registries

Medical imaging practices and radiologists now can claim Merit-based Incentive Payment System (MIPS) “Improvement Activity” credits for contributing COVID-related data and images to the American College of Radiology® (ACR®) COVID-19 Imaging Research Registry (CIRR) or ACR Lung Cancer Screening Registry (LCSR).

Practices and clinicians can earn Centers for Medicare and Medicaid Services (CMS) bonus payments and avoid CMS penalties by completing MIPS requirements.

“As a result of ACR-backed CMS policy updates to address the COVID-19 public health emergency, CIRR and LCSR participation enables most radiologists[1]and practices[2] to fully meet yearly MIPS Improvement Activity requirements,” said William T. Thorwarth Jr., MD, FACR, ACR Chief Executive Officer. “Radiologists and imaging practices should take advantage of this opportunity.”

CIRR is the newest of the six registries that form the ACR National Clinical Imaging Research Registry™ (ANCIRR).  ANCIRR registries collect and curate images and clinical data from many practice settings to produce large data sets that enable researchers to address complex questions and produce results applicable across care settings, locations and populations. CIRR is a primary data collector for the National Institute of Biomedical Imaging and Bioengineering (NIBIB)-funded Medical Imaging and Data Resource Center (MIDRC) — which may become the world’s largest COVID-19 imaging archive.

“CIRR participation enables radiologists and practices that have never taken part in research to help move patient care forward, aid health equity efforts and strengthen their practice by satisfying an increasing number of MIPS requirements,” said Sharyn I. Katz, MD, MTR, principal investigator of the ACR COVID-19 Imaging Research Registry. “Now is the time to take part in CIRR.”

The LCSR is one of the seven registries that comprise the ACR National Radiology Data Registry (NRDR®). NRDR receives data from facilities to enable practice quality improvement through site feedback and benchmarking against peers. Data contributed to NRDR is made available for exploring a wide range of questions about radiology practice and new areas for site improvement.

“Contributing to the LCSR not only fuels advances against the nation’s leading cancer killer, but against COVID-19 — which continues to kill thousands nationwide,” said Charles White, MD, FACR, Chair of the ACR Lung Cancer Screening Registry Committee. “With the added ability to satisfy certain MIPS requirements, lung cancer screening sites can help their practice and countless future patients through LCSR participation.”

Get ANCIRR information at acr.org/researchregistry.

Get NRDR information at https://www.acr.org/Practice-Management-Quality-Informatics/Registries.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”